[
  {
    "objectID": "people/arbones-jm/index.html#education",
    "href": "people/arbones-jm/index.html#education",
    "title": "Jose M. Arbones-Mainar",
    "section": "Education",
    "text": "Education\nM.Sc. Omics Data Analysis | University of Vic | 2024  Ph.D. Medicine | University of Zaragoza | 2005  B.S. Biochemistry & Molecular and cellular biology | University of Zaragoza | 2005  Pharm.D. | University of Navarra |1997"
  },
  {
    "objectID": "people/arbones-jm/index.html#affiliations",
    "href": "people/arbones-jm/index.html#affiliations",
    "title": "Jose M. Arbones-Mainar",
    "section": "Affiliations",
    "text": "Affiliations\nInstituto Aragonés de Ciencias de la SaludInstituto de Investigación Sanitaria AragónCIBER Fisiopatología de la Obesidad y Nutrición"
  },
  {
    "objectID": "people/bernal-vanesa/index.html#education",
    "href": "people/bernal-vanesa/index.html#education",
    "title": "Vanesa Bernal-Monterde",
    "section": "Education",
    "text": "Education\nPh.D. Medicine | University of Zaragoza | 2010  M.D. Medicine | University of Zaragoza | 2004"
  },
  {
    "objectID": "people/bernal-vanesa/index.html#affiliations",
    "href": "people/bernal-vanesa/index.html#affiliations",
    "title": "Vanesa Bernal-Monterde",
    "section": "Affiliations",
    "text": "Affiliations\nMiguel Servet University HospitalInstituto de Investigación Sanitaria Aragón"
  },
  {
    "objectID": "people/lorente-silvia/index.html#education",
    "href": "people/lorente-silvia/index.html#education",
    "title": "Silvia Lorente-Cebrian",
    "section": "Education",
    "text": "Education\nPh.D. Pharmacy | University of Navarra | Year  Pharm.D. | University of Navarra | Year"
  },
  {
    "objectID": "people/lorente-silvia/index.html#affiliations",
    "href": "people/lorente-silvia/index.html#affiliations",
    "title": "Silvia Lorente-Cebrian",
    "section": "Affiliations",
    "text": "Affiliations\nUniversidad de ZaragozaInstituto de Investigación Sanitaria Aragón"
  },
  {
    "objectID": "people/casamayor-menchu/index.html#education",
    "href": "people/casamayor-menchu/index.html#education",
    "title": "Carmen Casamayor-Franco",
    "section": "Education",
    "text": "Education\nPh.D. Medicine | University of Zaragoza | 1993  M.D. | University of Zaragoza | 2002"
  },
  {
    "objectID": "people/casamayor-menchu/index.html#affiliations",
    "href": "people/casamayor-menchu/index.html#affiliations",
    "title": "Carmen Casamayor-Franco",
    "section": "Affiliations",
    "text": "Affiliations\nMiguel Servet University Hospital  Instituto de Investigación Sanitaria Aragón"
  },
  {
    "objectID": "pubs.html",
    "href": "pubs.html",
    "title": "PUBLICATIONS",
    "section": "",
    "text": "2024\nThe dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk. Valdecantos MP, Ruiz L, Folgueira C, Rada P, Gomez-Santos B, Solas M, Hitos AB, Field J, Francisco V, Escalona-Garrido C, Zagmutt S, Calderon-Dominguez M, Mera P, Garcia-Martinez I, Maymó-Masip E, Grajales D, Alen R, Mora A, Sáinz N, Vides-Urrestarazu I, Vilarrasa N, Arbones-Mainar JM, Zaragoza C, Moreno-Aliaga MJ, Aspichueta P, Fernández-Veledo S, Vendrell J, Serra D, Herrero L, Schreiber R, Zechner R, Sabio G, Hornigold D, Rondinone CM, Jermutus L, Grimsby J, Valverde ÁM Nature communications . 15 ; 10342\nUnraveling the Association of Liver Steatosis and Fibrosis with Vitamin B12: A Cross-Sectional Study. Espina S, Casas-Deza D, Bernal-Monterde V, Royo-Esteban A, García-Sobreviela MP, Calmarza P, Martinez-Martinez AB, Osada J, Arbones-Mainar JM Metabolites . 14 ;\nPolyphenols and metabolism: from present knowledge to future challenges. Quesada-Vázquez S, Eseberri I, Les F, Pérez-Matute P, Herranz-López M, Atgié C, Lopez-Yus M, Aranaz P, Oteo JA, Escoté X, Lorente-Cebrian S, Roche E, Courtois A, López V, Portillo MP, Milagro FI, Carpéné C Journal of physiology and biochemistry . 80 ; 603-625\nMASLD-Related Hepatocarcinoma: Special Features and Challenges. Yagüe-Caballero C, Casas-Deza D, Pascual-Oliver A, Espina-Cadena S, Arbones-Mainar JM, Bernal-Monterde V Journal of clinical medicine . 13 ;\nLipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery. Herrera-Marcos LV, Arbones-Mainar JM, Osada J International journal of molecular sciences . 25 ;\nReduced adipocyte glutaminase activity promotes energy expenditure and metabolic health. Lecoutre S, Maqdasy S, Rizo-Roca D, Renzi G, Vlassakev I, Alaeddine LM, Higos R, Jalkanen J, Zhong J, Zareifi DS, Frendo-Cumbo S, Massier L, Hodek O, Juvany M, Moritz T, de Castro Barbosa T, Omar-Hmeadi M, López-Yus M, Merabtene F, Abatan JB, Marcelin G, El Hachem EJ, Rouault C, Bergo MO, Petrus P, Zierath JR, Clément K, Krook A, Mejhert N, Rydén M Nature metabolism . 6 ; 1329-1346\nExploring Functional Products and Early-Life Dynamics of Gut Microbiota. Martínez-Martínez AB, Lamban-Per BM, Lezaun M, Rezusta A, Arbones-Mainar JM Nutrients . 16 ;\nLipid Profile and Cardiovascular Risk Modification after Hepatitis C Virus Eradication. Pascual-Oliver A, Casas-Deza D, Yagüe-Caballero C, Arbones-Mainar JM, Bernal-Monterde V Pathogens (Basel, Switzerland) . 13 ;\nBone metabolism in children with normal weight and overweight/obesity in a northeastern region of Spain. Cuenca Alcocel J, Villalba-Heredia L, Martínez Redondo I, Berrozpe-Villabona C, Casajús JA, Arbonés-Mainar JM, Calmarza P Advances in laboratory medicine . 5 ; 66-74\n[Not Available]. Cuenca Alcocel J, Villalba-Heredia L, Martínez Redondo I, Berrozpe-Villabona C, Casajús JA, Arbonés-Mainar JM, Calmarza P Advances in laboratory medicine . 5 ; 75-84\nPredictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity. Moratiel Pellitero A, Zapata Garcia M, Gascon Ruiz M, Arbones-Mainar JM, Lastra Del Prado R, Isla D World journal of oncology . 15 ; 223-238\nUnraveling Adipose Tissue Dysfunction: Molecular Mechanisms, Novel Biomarkers, and Therapeutic Targets for Liver Fat Deposition. Lopez-Yus M, Hörndler C, Borlan S, Bernal-Monterde V, Arbones-Mainar JM Cells . 13 ;\nScreening and risk of hepatocellular carcinoma in patients with advanced fibrosis after hepatitis C virus eradication. Espina Cadena S, Casas Deza D, Julián Gomara B, Borao Laguna CV, Sierra Gabarda O, Lamuela Calvo LJ, Lorente S, Serrano T, Arbonés Mainar JM, Bernal Monterde V Revista espanola de enfermedades digestivas . 116 ; 305-311\n2023\nIsthmin-1 (ISM1), a novel adipokine that reflects abdominal adipose tissue distribution in individuals with obesity. Lopez-Yus M, Casamayor C, Soriano-Godes JJ, Borlan S, Gonzalez-Irazabal Y, Garcia-Sobreviela MP, Garcia-Rodriguez B, Del Moral-Bergos R, Calmarza P, Artigas JM, Lorente-Cebrian S, Bernal-Monterde V, Sanz-Paris A, Arbones-Mainar JM Cardiovascular diabetology . 22 ; 335\nCRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro. Lopez-Yus M, Frendo-Cumbo S, Del Moral-Bergos R, Garcia-Sobreviela MP, Bernal-Monterde V, Rydén M, Lorente-Cebrian S, Arbones-Mainar JM American journal of physiology. Cell physiology . 325 ; C1178-C1189\nLiver Disease Undernutrition Screening Tool Questionnaire Predicts Decompensation and Mortality in Cirrhotic Outpatients with Portal Hypertension. Casas-Deza D, Bernal-Monterde V, Betoré-Glaria E, Julián-Gomara AB, Yagüe-Caballero C, Sanz-París A, Fernández-Bonilla EM, Fuentes-Olmo J, Arbones-Mainar JM Nutrients . 15 ;\nPercutaneous left atrial appendage closure in patients with gastrointestinal bleeding associated with oral anticoagulants. Sanz Segura P, Jimeno Sánchez J, Arbonés-Mainar JM, Sánchez-Rubio Lezcano J, Galache Osuna G, Bernal Monterde V Scandinavian journal of gastroenterology . 58 ; 1547-1554\nMaresin 1 Exerts a Tissue-Specific Regulation of Adipo-Hepato-Myokines in Diet-Induced Obese Mice and Modulates Adipokine Expression in Cultured Human Adipocytes in Basal and Inflammatory Conditions. Martínez-Fernández L, Burgos M, Sáinz N, Laiglesia LM, Arbones-Mainar JM, González-Muniesa P, Moreno-Aliaga MJ Biomolecules . 13 ;\nMaresin 1 activates brown adipose tissue and promotes browning of white adipose tissue in mice. Laiglesia LM, Escoté X, Sáinz N, Felix-Soriano E, Santamaría E, Collantes M, Fernández-Galilea M, Colón-Mesa I, Martínez-Fernández L, Quesada-López T, Quesada-Vázquez S, Rodríguez-Ortigosa C, Arbones-Mainar JM, Valverde ÁM, Martínez JA, Dalli J, Herrero L, Lorente-Cebrián S, Villarroya F, Moreno-Aliaga MJ Molecular metabolism . 74 ; 101749\nTriglyceride-rich lipoproteins and insulin resistance in patients with chronic hepatitis C receiving direct-acting antivirals. Casas-Deza D, Espina S, Martínez-Sapiña A, Del Moral-Bergos R, Garcia-Sobreviela MP, Lopez-Yus M, Calmarza P, Bernal-Monterde V, Arbones-Mainar JM Atherosclerosis . 375 ; 59-66\nGene Therapy Based on Mesenchymal Stem Cells Derived from Adipose Tissue for the Treatment of Obesity and Its Metabolic Complications. Lopez-Yus M, García-Sobreviela MP, Del Moral-Bergos R, Arbones-Mainar JM International journal of molecular sciences . 24 ;\nEffectiveness and Safety of Ustekinumab in Elderly Patients with Crohn’s Disease: Real World Evidence From the ENEIDA Registry. Casas-Deza D, Lamuela-Calvo LJ, Gomollón F, Arbonés-Mainar JM, Caballol B, Gisbert JP, Rivero M, Sánchez-Rodríguez E, Arias García L, Gutiérrez Casbas A, Merino O, Márquez L, Laredo V, Martín-Arranz MD, López Serrano P, Riestra Menéndez S, González-Muñoza C, de Castro Parga L, Calvo Moya M, Fuentes-Valenzuela E, Esteve M, Iborra M, Dura Gil M, Barreiro-De Acosta M, Lorente-Poyatos RH, Manceñido N, Calafat M, Rodríguez-Lago I, Guardiola Capo J, Payeras MA, Morales Alvarado VJ, Tardillo C, Bujanda L, Muñoz-Nuñez JF, Ber Nieto Y, Bermejo F, Almela P, Navarro-Llavat M, Martínez Montiel P, Rodríguez Gutiérrez C, Van Domselaar M, Sesé E, Martínez Pérez T, Ricart E, Chaparro M, García MJ, López-Sanromán A, Sicilia B, Orts B, López-García A, Martín-Arranz E, Pérez-Calle JL, de Francisco R, García-Planella E, Domènech E, García-López YS Journal of Crohn’s & colitis . 17 ; 83-91\n2022\nRole of Branched-Chain Amino Acids and Their Derivative β-Hydroxy-β-Methylbutyrate in Liver Cirrhosis. Espina S, Sanz-Paris A, Bernal-Monterde V, Casas-Deza D, Arbonés-Mainar JM Journal of clinical medicine . 11 ;\nCardiorespiratory fitness decreases the odds for subclinical carotid plaques in apolipoprotein e4 homozygotes. Perez-Lasierra JL, Casajús JA, Gonzalez-Agüero A, Arbones-Mainar JM, Casasnovas JA, Laclaustra M, Moreno-Franco B Scientific reports . 12 ; 19196\nDiagnosis of Malnutrition According to GLIM Criteria Predicts Complications and 6-Month Survival in Cancer Outpatients. Gascón-Ruiz M, Casas-Deza D, Marti-Pi M, Torres-Ramón I, Zapata-García M, Sesma A, Lambea J, Álvarez-Alejandro M, Quilez E, Isla D, Arbonés-Mainar JM Biomedicines . 10 ;\nRheological Properties and Stability of Thickeners for Clinical Use. Calmarza-Chueca F, Sánchez-Gimeno AC, Raso-Pueyo J, Arbones-Mainar JM, Caverni-Muñoz A, Sanz-Arque A, Sanz-Paris A Nutrients . 14 ;\nEvaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease. Casas-Deza D, Martínez-Sapiña A, Espina S, Garcia-Rodriguez B, Fernandez-Bonilla EM, Sanz-Paris A, Gonzalez-Irazabal Y, Bernal-Monterde V, Arbones-Mainar JM Journal of clinical medicine . 11 ;\n[Impact of Staphylococcus aureus bacteremia in COVID-19 patients]. Espinosa Perez M, García Fenoll R, Mormeneo Bayo S, Martínez Álvarez RM, Frutos Millán V, Villuendas Usón MC, Palacián Ruiz MP, Arbonés Mainar JM, Martínez Jiménez MC, Ramos Paesa C Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia . 35 ; 468-474\nIdentification of novel targets in adipose tissue involved in non-alcoholic fatty liver disease progression. Lopez-Yus M, Lorente-Cebrian S, Del Moral-Bergos R, Hörndler C, Garcia-Sobreviela MP, Casamayor C, Sanz-Paris A, Bernal-Monterde V, Arbones-Mainar JM FASEB journal : official publication of the Federation of American Societies for Experimental Biology . 36 ; e22429\nRandomized Clinical Trial: Effects of β-Hydroxy-β-Methylbutyrate (HMB)-Enriched vs. HMB-Free Oral Nutritional Supplementation in Malnourished Cirrhotic Patients. Espina S, Sanz-Paris A, Gonzalez-Irazabal Y, Pérez-Matute P, Andrade F, Garcia-Rodriguez B, Carpéné C, Zakaroff A, Bernal-Monterde V, Fuentes-Olmo J, Arbones-Mainar JM Nutrients . 14 ;\nColorectal cancer: immune response in laparoscopic versus open colorectal surgery. Martínez-Martínez AB, Arbonés-Mainar JM Cirugia y cirujanos . 90 ; 295-302\nAssociation of Cholesterol and Oxysterols in Adipose Tissue With Obesity and Metabolic Syndrome Traits. Baila-Rueda L, Cenarro A, Lamiquiz-Moneo I, Marco-Benedi V, Gracia-Rubio I, Casamayor-Franco MC, Arbones-Mainar JM, Civeira F, Laclaustra M The Journal of clinical endocrinology and metabolism . 107 ; e3929-e3936\nComparation of different malnutrition screening tools according to GLIM criteria in cancer outpatients. Gascón-Ruiz M, Casas-Deza D, Torres-Ramón I, Zapata-García M, Alonso N, Sesma A, Lambea J, Álvarez-Alejandro M, Quílez E, Isla D, Arbonés-Mainar JM European journal of clinical nutrition . 76 ; 698-702\nAn adaptation of meaning-centered psychotherapy integrating “essential care”: A pilot study. Quílez-Bielsa E, Barrado-Moreno V, Lastra Del Prado R, Arbonés-Mainar JM, Sebastian-Sanchez M, Ventura-Faci T Palliative & supportive care . 20 ; 496-504\nAdiponectin overexpression in C2C12 myocytes increases lipid oxidation and myofiber transition. Lopez-Yus M, Lopez-Perez R, Garcia-Sobreviela MP, Del Moral-Bergos R, Lorente-Cebrian S, Arbones-Mainar JM Journal of physiology and biochemistry . 78 ; 517-525\n2021\nAge-related mortality in 61,993 confirmed COVID-19 cases over three epidemic waves in Aragon, Spain. Implications for vaccination programmes. Casas-Deza D, Bernal-Monterde V, Aranda-Alonso AN, Montil-Miguel E, Julián-Gomara AB, Letona-Giménez L, Arbones-Mainar JM PloS one . 16 ; e0261061\nAmino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy. Espina S, Gonzalez-Irazabal Y, Sanz-Paris A, Lopez-Yus M, Garcia-Sobreviela MP, Del Moral-Bergos R, Garcia-Rodriguez B, Fuentes-Olmo J, Bernal-Monterde V, Arbones-Mainar JM Nutrients . 13 ;\nInstitutionalized elderly are able to detect small viscosity variations in thickened water with gum-based thickeners: should texture classifications be reviewed? Calmarza-Chueca F, Cristina-Sánchez-Gimeno A, Perez-Nogueras J, Caverni-Muñoz A, Sanz-Arque A, Arbones-Mainar JM, Sanz-Paris A BMC geriatrics . 21 ; 647\nRegulation of p27 and Cdk2 Expression in Different Adipose Tissue Depots in Aging and Obesity. Colón-Mesa I, Fernández-Galilea M, Sáinz N, Lopez-Yus M, Artigas JM, Arbonés-Mainar JM, Félix-Soriano E, Escoté X, Moreno-Aliaga MJ International journal of molecular sciences . 22 ;\nMasseter Muscle Thickness Measured by Ultrasound as a Possible Link with Sarcopenia, Malnutrition and Dependence in Nursing Homes. González-Fernández M, Perez-Nogueras J, Serrano-Oliver A, Torres-Anoro E, Sanz-Arque A, Arbones-Mainar JM, Sanz-Paris A Diagnostics (Basel, Switzerland) . 11 ;\nMuscle Thickness and Echogenicity Measured by Ultrasound Could Detect Local Sarcopenia and Malnutrition in Older Patients Hospitalized for Hip Fracture. Sanz-Paris A, González-Fernandez M, Hueso-Del Río LE, Ferrer-Lahuerta E, Monge-Vazquez A, Losfablos-Callau F, Sanclemente-Hernández T, Sanz-Arque A, Arbones-Mainar JM Nutrients . 13 ;\nResponse to “Malnutrition in patients with cirrhosis: Screen or treat?”. Casas Deza D, Betoré Glaria ME, Sanz-París A, Lafuente Blasco M, Fernández Bonilla EM, Bernal Monterde V, Arbonés-Mainar JM, Fuentes Olmo J Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition . 36 ; 1093-1094\nCan Physical Activity Reduce the Risk of Cognitive Decline in Apolipoprotein e4 Carriers? A Systematic Review. Perez-Lasierra JL, Casajús JA, Casasnovas JA, Arbones-Mainar JM, Lobo A, Lobo E, Moreno-Franco B, Gonzalez-Agüero A International journal of environmental research and public health . 18 ;\nSuccessful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project. Calvo LLJ, García Cámara P, Llorente Barrio M, Sierra Gabarda O, Monzón Baez R, Arbonés Mainar JM, Alcedo González J, Bernal Monterde V European journal of clinical pharmacology . 77 ; 1927-1933\nGLIM vs ESPEN criteria for the diagnosis of early malnutrition in oncological outpatients. Gascón-Ruiz M, Casas-Deza D, Torres-Ramón I, Zapata-García M, Alonso N, Sesma A, Lambea J, Álvarez-Alejandro M, Quílez E, Isla D, Arbonés-Mainar JM Clinical nutrition (Edinburgh, Scotland) . 40 ; 3741-3747\nMini Nutritional Assessment - Short Form Is a Useful Malnutrition Screening Tool in Patients with Liver Cirrhosis, Using the Global Leadership Initiative for Malnutrition Criteria as the Gold Standard. Casas Deza D, Betoré Glaria ME, Sanz-París A, Lafuente Blasco M, Fernández Bonilla EM, Bernal Monterde V, Arbonés Mainar JM, Fuentes Olmo J Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition . 36 ; 1003-1010\nUltrasonographic Measurement of Masseter Muscle Thickness Associates with Oral Phase Dysphagia in Institutionalized Elderly Individuals. González-Fernández M, Arbones-Mainar JM, Ferrer-Lahuerta E, Perez-Nogueras J, Serrano-Oliver A, Torres-Anoro E, Sanz-Paris A Dysphagia . 36 ; 1031-1039\nMaresin 1 regulates insulin signaling in human adipocytes as well as in adipose tissue and muscle of lean and obese mice. Martínez-Fernández L, González-Muniesa P, Sáinz N, Escoté X, Martínez JA, Arbones-Mainar JM, Moreno-Aliaga MJ Journal of physiology and biochemistry . 77 ; 167-173\nGastrointestinal and liver immune-related adverse effects induced by immune checkpoint inhibitors: A descriptive observational study. Sanz-Segura P, García-Cámara P, Fernández-Bonilla E, Arbonés-Mainar JM, Bernal Monterde V Gastroenterologia y hepatologia . 44 ; 261-268\nPrevalence of Malnutrition and 1-Year All-Cause Mortality in Institutionalized Elderly Patients Comparing Different Combinations of the GLIM Criteria. Sanz-Paris A, González Fernández M, Perez-Nogueras J, Serrano-Oliver A, Torres-Anoro E, Sanz-Arque A, Arbones-Mainar JM JPEN. Journal of parenteral and enteral nutrition . 45 ; 1164-1171\n2020\nRock tea (Jasonia glutinosa (L.) DC.) polyphenolic extract inhibits triglyceride accumulation in 3T3-L1 adipocyte-like cells and obesity related enzymes in vitro. Les F, Cásedas G, Valero MS, Arbonés-Mainar JM, López V Food & function . 11 ; 8931-8938\n[Lipid metabolism alterations produced by hepatitis C virus in patients with chronic infection.]. Muñoz-Cabrejas A, Espina Cadena S, Arbonés-Mainar JM, Moreno-Franco B Revista espanola de salud publica . 94 ;\nBeyond the CNS: The many peripheral roles of APOE. Martínez-Martínez AB, Torres-Perez E, Devanney N, Del Moral R, Johnson LA, Arbones-Mainar JM Neurobiology of disease . 138 ; 104809\nGLIM Criteria at Hospital Admission Predict 8-Year All-Cause Mortality in Elderly Patients With Type 2 Diabetes Mellitus: Results From VIDA Study. Sanz-París A, Martín-Palmero A, Gomez-Candela C, García-Almeida JM, Burgos-Pelaez R, Sanz-Arque A, Espina S, Arbones-Mainar JM JPEN. Journal of parenteral and enteral nutrition . 44 ; 1492-1500\n2019\nGLUT12 and adipose tissue: Expression, regulation and its relation with obesity in mice. Gil-Iturbe E, Arbones-Mainar JM, Moreno-Aliaga MJ, Lostao MP Acta physiologica (Oxford, England) . 226 ; e13283\nAre Comorbidities Associated With Overall Survival in Patients With Oral Squamous Cell Carcinoma? Jariod-Ferrer ÚM, Arbones-Mainar JM, Gavin-Clavero MA, Simón-Sanz MV, Moral-Saez I, Cisneros-Gimeno AI, Martinez-Trufero J Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons . 77 ; 1906-1914\nEffects of the amino acid derivatives, β-hydroxy-β-methylbutyrate, taurine, and N-methyltyramine, on triacylglycerol breakdown in fat cells. Leroux M, Lemery T, Boulet N, Briot A, Zakaroff A, Bouloumié A, Andrade F, Pérez-Matute P, Arbones-Mainar JM, Carpéné C Journal of physiology and biochemistry . 75 ; 263-273\nNeck circumference is associated with nutritional status in elderly nursing home residents. Lardiés-Sánchez B, Arbones-Mainar JM, Perez-Nogueras J, Serrano-Oliver A, Torres-Anoro E, Sanz-Paris A Nutrition (Burbank, Los Angeles County, Calif.) . 62 ; 153-157\n2018\nThe Dietary Antioxidant Piceatannol Inhibits Adipogenesis of Human Adipose Mesenchymal Stem Cells and Limits Glucose Transport and Lipogenic Activities in Adipocytes. Carpéné C, Pejenaute H, Del Moral R, Boulet N, Hijona E, Andrade F, Villanueva-Millán MJ, Aguirre L, Arbones-Mainar JM International journal of molecular sciences . 19 ;\nPTRF acts as an adipokine contributing to adipocyte dysfunctionality and ectopic lipid deposition. Perez-Diaz S, Garcia-Sobreviela MP, Gonzalez-Irazabal Y, Garcia-Rodriguez B, Espina S, Arenaz I, Arbones-Mainar JM Journal of physiology and biochemistry . 74 ; 613-622\nPomegranate polyphenols and urolithin A inhibit α-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells. Les F, Arbonés-Mainar JM, Valero MS, López V Journal of ethnopharmacology . 220 ; 67-74\n2017\nPhenolic compounds apigenin, hesperidin and kaempferol reduce in vitro lipid accumulation in human adipocytes. Gómez-Zorita S, Lasa A, Abendaño N, Fernández-Quintela A, Mosqueda-Solís A, Garcia-Sobreviela MP, Arbonés-Mainar JM, Portillo MP Journal of translational medicine . 15 ; 237\nPharmacologic concentrations of linezolid modify oxidative phosphorylation function and adipocyte secretome. Llobet L, Bayona-Bafaluy MP, Pacheu-Grau D, Torres-Pérez E, Arbones-Mainar JM, Navarro MÁ, Gómez-Díaz C, Montoya J, López-Gallardo E, Ruiz-Pesini E Redox biology . 13 ; 244-254\nPost-lunch triglyceridaemia associates with HDLc and insulin resistance in fasting normotriglyceridaemic menopausal women. Sanz-Paris A, Rodriguez-Valle A, Navarro MA, Puzo-Foncillas J, Arbones-Mainar JM Journal of human nutrition and dietetics : the official journal of the British Dietetic Association . 30 ; 700-708\nMaresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob/ob and diet-induced obese mice. Martínez-Fernández L, González-Muniesa P, Laiglesia LM, Sáinz N, Prieto-Hontoria PL, Escoté X, Odriozola L, Corrales FJ, Arbones-Mainar JM, Martínez JA, Moreno-Aliaga MJ FASEB journal : official publication of the Federation of American Societies for Experimental Biology . 31 ; 2135-2145\nKnockdown of PTRF ameliorates adipocyte differentiation and functionality of human mesenchymal stem cells. Perez-Diaz S, Garcia-Rodriguez B, Gonzalez-Irazabal Y, Valero M, Lagos-Lizan J, Arbones-Mainar JM American journal of physiology. Cell physiology . 312 ; C83-C91\n2016\nPiceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties. Les F, Deleruyelle S, Cassagnes LE, Boutin JA, Balogh B, Arbones-Mainar JM, Biron S, Marceau P, Richard D, Nepveu F, Mauriège P, Carpéné C Chemico-biological interactions . 258 ; 115-25\nMetabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4. Arbones-Mainar JM, Johnson LA, Torres-Perez E, Garcia AE, Perez-Diaz S, Raber J, Maeda N International journal of obesity (2005) . 40 ; 1574-1581\nApplication of the new ESPEN definition of malnutrition in geriatric diabetic patients during hospitalization: A multicentric study. Sanz-París A, Gómez-Candela C, Martín-Palmero Á, García-Almeida JM, Burgos-Pelaez R, Matía-Martin P, Arbones-Mainar JM Clinical nutrition (Edinburgh, Scotland) . 35 ; 1564-1567\nInteraction of apolipoprotein E gene polymorphisms on miscarriage risk in black and white American women. Gamundi-Segura S, Torres-Perez E, Sanz-Paris A, Arbones-Mainar JM Fertility and sterility . 105 ; 1554-1560.e1\nLimited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: gut microbiota, metabolic, endocrine, and cardiac aspects. Hijona E, Aguirre L, Pérez-Matute P, Villanueva-Millán MJ, Mosqueda-Solis A, Hasnaoui M, Nepveu F, Senard JM, Bujanda L, Aldámiz-Echevarría L, Llarena M, Andrade F, Perio P, Leboulanger F, Hijona L, Arbones-Mainar JM, Portillo MP, Carpéné C Journal of physiology and biochemistry . 72 ; 567-82\nApolipoprotein E4 association with metabolic syndrome depends on body fatness. Torres-Perez E, Ledesma M, Garcia-Sobreviela MP, Leon-Latre M, Arbones-Mainar JM Atherosclerosis . 245 ; 35-42\nPotential renoprotective effects of piceatannol in ameliorating the early-stage nephropathy associated with obesity in obese Zucker rats. Llarena M, Andrade F, Hasnaoui M, Portillo MP, Pérez-Matute P, Arbones-Mainar JM, Hijona E, Villanueva-Millán MJ, Aguirre L, Carpéné C, Aldámiz-Echevarría L Journal of physiology and biochemistry . 72 ; 555-66\n2015\nBioactive properties of commercialised pomegranate (Punica granatum) juice: antioxidant, antiproliferative and enzyme inhibiting activities. Les F, Prieto JM, Arbonés-Mainar JM, Valero MS, López V Food & function . 6 ; 2049-57\nThe FAT expandability (FATe) Project: Biomarkers to determine the limit of expansion and the complications of obesity. Torres-Perez E, Valero M, Garcia-Rodriguez B, Gonzalez-Irazabal Y, Calmarza P, Calvo-Ruata L, Ortega C, Garcia-Sobreviela MP, Sanz-Paris A, Artigas JM, Lagos J, Arbones-Mainar JM Cardiovascular diabetology . 14 ; 40\nEffects of adipocyte-secreted factors on decidualized endometrial cells: modulation of endometrial receptivity in vitro. Gamundi-Segura S, Serna J, Oehninger S, Horcajadas JA, Arbones-Mainar JM Journal of physiology and biochemistry . 71 ; 537-46\n2014\nThe apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men. Tejedor MT, Garcia-Sobreviela MP, Ledesma M, Arbones-Mainar JM PloS one . 9 ; e108605\nPolymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability. Perez-Diaz S, Johnson LA, DeKroon RM, Moreno-Navarrete JM, Alzate O, Fernandez-Real JM, Maeda N, Arbones-Mainar JM FASEB journal : official publication of the Federation of American Societies for Experimental Biology . 28 ; 3769-79\n2013\nNovel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3. Oliván-Viguera A, Valero MS, Murillo MD, Wulff H, García-Otín AL, Arbonés-Mainar JM, Köhler R PloS one . 8 ; e58614\n2011\nApolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. Johnson LA, Arbones-Mainar JM, Fox RG, Pendse AA, Altenburg MK, Kim HS, Maeda N Diabetes . 60 ; 2285-94"
  },
  {
    "objectID": "projects.html",
    "href": "projects.html",
    "title": "Current Projects",
    "section": "",
    "text": "The Fat expandibility (FATe).\nObesity, characterized by excessive fat accumulation, poses health risks. Subcutaneous adipose tissue can expand during positive energy balance, but once its expansion capacity is exceeded, ectopic lipid deposition occurs in other organs. One prevalent comorbidity of obesity is intrahepatic lipid accumulation, as seen in metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD).\n\nThis project builds on the group’s primary research, initiated under the FATe Project, which studied adipose tissue expandability and aimed to identify non-invasive biomarkers for expansion limits and obesity-related complications. The initial study identified factors limiting subcutaneous adipose tissue expansion and stratified obese patients using biomarker-based predictive models (FASEB. 2022). Mesenchymal stem cell lines from diverse phenotypes were characterized.\nThen, the team focused on using CRISPR/Cas9 gene-editing technology to modify mesenchymal stem cells from adipose tissue, enhancing their functionality and differentiation into adipocytes with increased expansion capacity. Our results suggested that improving adipocyte expandability could reduce intrahepatic fat accumulation and offer therapeutic potential for NAFLD (Am J Physiol Cell Physiol. 2023).\nMoreover, given the limitations of traditional metrics like BMI and waist circumference in assessing obesity-related risks, we demonstrated that the SC/VIS fat ratio is a more effective metric for distinguishing metabolic health profiles. We identified ISM1 as a promising non-invasive biomarker, showing strong correlations with fat distribution, serum adipokines, and glucose regulation, highlighting its potential for improved obesity risk assessment (Cardiovascular Diabetol. 2023).\n\n\n\nWe mantain a continuously expanding cohort with over 500 individuals with obesity recruited since 2013 as part of the FATe Project. Participants undergo comprehensive characterization and have donated adipose tissue (subcutaneous and visceral), DNA, blood, and liver biopsies. Mesenchymal stem cells from the adipose tissue have been used to establish cell cultures. Omics techniques, including bulk and single-nuclei RNA sequencing, miRNA analysis, and exome sequencing, have been applied to selected subgroups.\nThis cohort actively supports the group’s research projects and would be available for national and international collaborations.\n\nInteractive view of the patients´characteristics and available samples within the cohort\n\n\n\n\nNew biomarkers for MASLD and hepatocellular carcinoma (HCC)\nMetabolic dysfunction-associated steatotic liver disease (MASLD), a widespread condition, encompasses a spectrum from simple steatosis (“fatty liver”) to steatohepatitis (SH). SH can escalate into non-alcoholic steatohepatitis (MASH), which may further progress to advanced fibrosis (cirrhosis), hepatocellular carcinoma (HCC), and liver failure. The prevalence of MASLD is expected to rise due to the global obesity epidemic driven by sedentary lifestyles and poor dietary habits.\nLiver biopsy is the gold standard for evaluating MASLD stages but has significant limitations. It carries risks of complications, sampling variability, and limited representativeness due to the small tissue area analyzed. Moreover, it is unsuitable for long-term dynamic monitoring of fibrosis. Consequently, developing reliable non-invasive methods to stage MASLD is critical for tracking disease progression and guiding therapy. While various non-invasive models combining clinical and routine lab analytes have been proposed, their diagnostic value remains controversial.\nOver recent years, gene expression profiling of human cells and tissues has advanced the understanding of molecular mechanisms and potential predictive biomarkers for metabolic diseases such as obesity and diabetes. While several studies have sought genetic profiles to differentiate MASLD stages, hepatic transcriptomic biomarkers specific to detecting MASH and predicting its progression remain untested in clinical practice. Limitations include small sample sizes, lack of replication cohorts, insufficient focus on transcriptional differences between steatosis and advanced fibrosis, and challenges in translating candidate genes into standard clinical assays.\nOur team is engaged in two national projects funded by the Instituto de Salud Carlos III: a consortium in the personalized medicine framework (PMP21/00094) and a single-center initiative (PI22/01366). These aim to develop innovative methodologies combining gene expression analyses with advanced statistical techniques to create non-invasive biomarkers for tracking MASLD progression and identifying patients at high risk for HCC. These efforts focus on:\n\n\n\n\nEnhancing understanding of the molecular mechanisms underlying liver diseases.\nProposing new therapeutic targets for drug development.\nIdentifying transcriptional patterns specific to fibrosis, shedding light on the molecular drivers of inflammation and prefibrotic states.\n\nWe will integrate transcriptomic data with established predictors (e.g., FIB-4, APRI, NFS) and advanced computational methods, including AI, to refine biomarker discovery. Particular attention will be given to genes encoding secreted proteins, aiming to create accessible and scalable diagnostic tools for early detection and therapeutic interventions.\nThis approach seeks to bridge current gaps in MASLD management, facilitating early diagnosis, risk stratification, and improved clinical outcomes for patients at risk of progressing to HCC."
  },
  {
    "objectID": "index.html",
    "href": "index.html",
    "title": "",
    "section": "",
    "text": "Welcome to the website of the ADIPOcyte and FAT biology Lab.\n\nWe study adipocyte biology and its role in health and disease. Collaborating with basic and clinical researchers, we focus on the pathophysiological effects of obesity, particularly the metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to liver cancer.\nOur work aims to identify biomarkers and develop approaches for personalized medicine, addressing the challenges faced by obese patients and the professionals who care for them.\nWe apply advanced omics technologies and AI tools, including large language models (LLMs), to improve our understanding and find practical solutions."
  },
  {
    "objectID": "people/garcia-mapi/index.html#education",
    "href": "people/garcia-mapi/index.html#education",
    "title": "Mapi García-Sobreviela",
    "section": "Education",
    "text": "Education\nSuperior Laboratory TechnicianSpecialization Chemical Analysis and Control | 2003"
  },
  {
    "objectID": "people/garcia-mapi/index.html#affiliations",
    "href": "people/garcia-mapi/index.html#affiliations",
    "title": "Mapi García-Sobreviela",
    "section": "Affiliations",
    "text": "Affiliations\nInstituto de Investigación Sanitaria Aragón"
  },
  {
    "objectID": "people/index.html",
    "href": "people/index.html",
    "title": "Meet the Group",
    "section": "",
    "text": "Jose M. Arbones-Mainar \n            \n               \n            \n              Senior Scientist\n            \n                \n            \n              \n              \n                \n                \n                  M.Sc. Omics Data Analysis | University of Vic | 2024  Ph.D. Medicine | University of Zaragoza | 2005  B.S. Biochemistry & Molecular and cellular biology | University of Zaragoza | 2005  Pharm.D. | University of Navarra |1997\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Vanesa Bernal-Monterde \n            \n               \n            \n              Attending Physician  Clinical Scientist  Liver Unit  GI department\n            \n                \n            \n              \n              \n                \n                \n                  Ph.D. Medicine | University of Zaragoza | 2010  M.D. Medicine | University of Zaragoza | 2004\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n    \n  \n\n\n\n\nNo matching items"
  },
  {
    "objectID": "people/index.html#principal-investigators",
    "href": "people/index.html#principal-investigators",
    "title": "Meet the Group",
    "section": "",
    "text": "Jose M. Arbones-Mainar \n            \n               \n            \n              Senior Scientist\n            \n                \n            \n              \n              \n                \n                \n                  M.Sc. Omics Data Analysis | University of Vic | 2024  Ph.D. Medicine | University of Zaragoza | 2005  B.S. Biochemistry & Molecular and cellular biology | University of Zaragoza | 2005  Pharm.D. | University of Navarra |1997\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Vanesa Bernal-Monterde \n            \n               \n            \n              Attending Physician  Clinical Scientist  Liver Unit  GI department\n            \n                \n            \n              \n              \n                \n                \n                  Ph.D. Medicine | University of Zaragoza | 2010  M.D. Medicine | University of Zaragoza | 2004\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n    \n  \n\n\n\n\nNo matching items"
  },
  {
    "objectID": "people/index.html#research-scientists",
    "href": "people/index.html#research-scientists",
    "title": "Meet the Group",
    "section": "Research Scientists",
    "text": "Research Scientists\n\n\n\n  \n   \n\n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Mapi García-Sobreviela \n            \n               \n            \n              Lab Manager\n            \n                \n            \n              \n              \n                \n                \n                  Superior Laboratory TechnicianSpecialization Chemical Analysis and Control | 2003\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Silvia Lorente-Cebrian \n            \n               \n            \n              Tenured Professor\n            \n                \n            \n              \n              \n                \n                \n                  Ph.D. Pharmacy | University of Navarra | Year  Pharm.D. | University of Navarra | Year\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Raquel del Moral-Bergós \n            \n               \n            \n              Staff Scientist\n            \n                \n            \n              \n              \n                \n                \n                  Ph.D. in Sociology of Public and Social Policies | University of Zaragoza | 2019  B.S. Biochemistry & Molecular and cellular biology | University of Zaragoza | 2010  B.S. Biology | Complutense University of Madrid | 2005\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n    \n  \n\n\n\n\nNo matching items"
  },
  {
    "objectID": "people/index.html#clinical-scientists",
    "href": "people/index.html#clinical-scientists",
    "title": "Meet the Group",
    "section": "Clinical Scientists",
    "text": "Clinical Scientists\n\n\n\n  \n   \n\n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Carmen Casamayor-Franco \n            \n               \n            \n              Attending Surgeon  Head of the Bariatric and Metabolic Surgery Unit\n            \n                \n            \n              \n              \n                \n                \n                  Ph.D. Medicine | University of Zaragoza | 1993  M.D. | University of Zaragoza | 2002\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n    \n  \n\n\n\n\nNo matching items"
  },
  {
    "objectID": "people/index.html#post-baccalaureate-researchers",
    "href": "people/index.html#post-baccalaureate-researchers",
    "title": "Meet the Group",
    "section": "Post Baccalaureate Researchers",
    "text": "Post Baccalaureate Researchers\n\n\n\n  \n   \n\n     \n    \n    \n      \n      \n      \n      \n        \n          \n          \n          \n            \n          \n          \n          \n            \n            \n              Marina Clavel-Millan \n            \n               \n            \n              \n            \n                \n            \n              \n              \n                \n                \n                  M.Sc. in Hospital Pharmaceutical Sciences | CEU Cardenal Herrera University | 2024  Pharm.D. | University of Alacalá | 2021\n                  \n                    \n                \n                  \n\n            \n            \n            \n          \n      \n      \n    \n  \n    \n  \n\n\n\n\nNo matching items"
  },
  {
    "objectID": "people/clavel-marina/index.html#education",
    "href": "people/clavel-marina/index.html#education",
    "title": "Marina Clavel-Millan",
    "section": "Education",
    "text": "Education\nM.Sc. in Hospital Pharmaceutical Sciences | CEU Cardenal Herrera University | 2024  Pharm.D. | University of Alacalá | 2021"
  },
  {
    "objectID": "people/clavel-marina/index.html#affiliations",
    "href": "people/clavel-marina/index.html#affiliations",
    "title": "Marina Clavel-Millan",
    "section": "Affiliations",
    "text": "Affiliations\nInstituto de Investigación Sanitaria Aragón"
  },
  {
    "objectID": "people/delmoral-raquel/index.html#education",
    "href": "people/delmoral-raquel/index.html#education",
    "title": "Raquel del Moral-Bergós",
    "section": "Education",
    "text": "Education\nPh.D. in Sociology of Public and Social Policies | University of Zaragoza | 2019  B.S. Biochemistry & Molecular and cellular biology | University of Zaragoza | 2010  B.S. Biology | Complutense University of Madrid | 2005"
  },
  {
    "objectID": "people/delmoral-raquel/index.html#affiliations",
    "href": "people/delmoral-raquel/index.html#affiliations",
    "title": "Raquel del Moral-Bergós",
    "section": "Affiliations",
    "text": "Affiliations\nInstituto Aragonés de Cienciasd de la SaludInstituto de Investigación Sanitaria Aragón"
  }
]